Pyrazole compounds as sglt1 inhibitors
The present invention provides a compound of Formula (II); wherein X represents the moieties shown in the accompanying figure; or a pharmaceutically acceptable salt thereof. The compounds are inhibitors of SGLT1 which may be suitable for the treatment of diabetes.
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Format: | Patent |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | QU FUCHENG MANTLO NATHAN BRYAN |
| description | The present invention provides a compound of Formula (II); wherein X represents the moieties shown in the accompanying figure; or a pharmaceutically acceptable salt thereof. The compounds are inhibitors of SGLT1 which may be suitable for the treatment of diabetes. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_NZ700356A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>NZ700356A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_NZ700356A3</originalsourceid><addsrcrecordid>eNrjZFALqCxKrMrPSVVIzs8tyC_NSylWSCxWKE7PKTFUyMzLyEzKLMkvKuZhYE1LzClO5YXS3Axybq4hzh66qQX58anFBYnJqXmpJfF-UeYGBsamZo7GBBUAAKT0Jqc</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Pyrazole compounds as sglt1 inhibitors</title><source>esp@cenet</source><creator>QU FUCHENG ; MANTLO NATHAN BRYAN</creator><creatorcontrib>QU FUCHENG ; MANTLO NATHAN BRYAN</creatorcontrib><description>The present invention provides a compound of Formula (II); wherein X represents the moieties shown in the accompanying figure; or a pharmaceutically acceptable salt thereof. The compounds are inhibitors of SGLT1 which may be suitable for the treatment of diabetes.</description><language>eng</language><subject>CHEMISTRY ; DERIVATIVES THEREOF ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; NUCLEIC ACIDS ; NUCLEOSIDES ; NUCLEOTIDES ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS ; SUGARS</subject><creationdate>2016</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20160624&DB=EPODOC&CC=NZ&NR=700356A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20160624&DB=EPODOC&CC=NZ&NR=700356A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>QU FUCHENG</creatorcontrib><creatorcontrib>MANTLO NATHAN BRYAN</creatorcontrib><title>Pyrazole compounds as sglt1 inhibitors</title><description>The present invention provides a compound of Formula (II); wherein X represents the moieties shown in the accompanying figure; or a pharmaceutically acceptable salt thereof. The compounds are inhibitors of SGLT1 which may be suitable for the treatment of diabetes.</description><subject>CHEMISTRY</subject><subject>DERIVATIVES THEREOF</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>NUCLEIC ACIDS</subject><subject>NUCLEOSIDES</subject><subject>NUCLEOTIDES</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><subject>SUGARS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2016</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZFALqCxKrMrPSVVIzs8tyC_NSylWSCxWKE7PKTFUyMzLyEzKLMkvKuZhYE1LzClO5YXS3Axybq4hzh66qQX58anFBYnJqXmpJfF-UeYGBsamZo7GBBUAAKT0Jqc</recordid><startdate>20160624</startdate><enddate>20160624</enddate><creator>QU FUCHENG</creator><creator>MANTLO NATHAN BRYAN</creator><scope>EVB</scope></search><sort><creationdate>20160624</creationdate><title>Pyrazole compounds as sglt1 inhibitors</title><author>QU FUCHENG ; MANTLO NATHAN BRYAN</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_NZ700356A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2016</creationdate><topic>CHEMISTRY</topic><topic>DERIVATIVES THEREOF</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>NUCLEIC ACIDS</topic><topic>NUCLEOSIDES</topic><topic>NUCLEOTIDES</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><topic>SUGARS</topic><toplevel>online_resources</toplevel><creatorcontrib>QU FUCHENG</creatorcontrib><creatorcontrib>MANTLO NATHAN BRYAN</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>QU FUCHENG</au><au>MANTLO NATHAN BRYAN</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Pyrazole compounds as sglt1 inhibitors</title><date>2016-06-24</date><risdate>2016</risdate><abstract>The present invention provides a compound of Formula (II); wherein X represents the moieties shown in the accompanying figure; or a pharmaceutically acceptable salt thereof. The compounds are inhibitors of SGLT1 which may be suitable for the treatment of diabetes.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng |
| recordid | cdi_epo_espacenet_NZ700356A |
| source | esp@cenet |
| subjects | CHEMISTRY DERIVATIVES THEREOF HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY NUCLEIC ACIDS NUCLEOSIDES NUCLEOTIDES ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS SUGARS |
| title | Pyrazole compounds as sglt1 inhibitors |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-18T22%3A50%3A54IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=QU%20FUCHENG&rft.date=2016-06-24&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ENZ700356A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |